Response of biochemical markers of bone turnover to estrogen treatment in post-menopausal women: Evidence against an early anabolic effect on bone formation

Journal of Endocrinological Investigation

Volumn 24, Issue 6, 2001, Pages 423-429

  Fiore, C E ^a   Pennisi, P ^a   Tandurella, F G ^a   Amato, R ^a   Giuliano, L ^a   Amico, A ^a   Sciacchitano, G S ^a   Caschetto, S ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Bone formation; Bone markers; Hormone replacement therapy; Menopause

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; CALCIUM; COLLAGEN TYPE 1; CREATININE; DEOXYPYRIDINOLINE; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; INTERLEUKIN 6; PHOSPHATE; PYRIDINOLINE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE ATROPHY; BONE METABOLISM; BONE TURNOVER; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; METABOLIC INHIBITION; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL;

ALKALINE PHOSPHATASE; AMINO ACIDS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE REMODELING; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INTERLEUKIN-6; MIDDLE AGED; PEPTIDE FRAGMENTS; POSTMENOPAUSE; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034972265     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03351042     Document Type: Article

References (25)

1. Long-term estrogen replacement therapy prevents bone loss and fractures
2. Reversal of postmenopausal bone loss by oestrogen and progestagen: A double-blind placebo controlled study
3. Normal and pathological remodeling of human trabecular bone: Three dimensional reconstruction of the remodeling sequence in normal and in metabolic bone disease
4. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis
5. Evidence of estrogen receptors in normal human osteoblast-like cells
6. Preliminary in-situ identification of estrogen target cells in bone
7. High-dose estrogen induces de novo medullary bone formation in female mice
8. Does estrogen stimulate osteoblast function in postmenopausal women?
9. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum
10. Immunoassay for urinary pyridinoline: The new marker of bone resorption
11. Direct enzyme-limited immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption
12. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture
13. A cross-sectional study of the effects of long-term percutaneous hormone replacement therapy on bone density
14. The effect of long-term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy
15. Estrogen does not increase bone formation in growing rats
16. Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability
17. Aminohexane bisphosphonate suppresses bone turnover in postmenopausal women more rapidly than oestrogen-gestagen therapy
18. Estrogen does not restore bone lost after ovariectomy in the rat
19. Early effects of hormone replacement therapy on bone
20. Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women
21. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens
22. Cytokines and bone loss in a 5-year longitudinal study. Hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: The Danish Osteoporosis Prevention study
23. Transforming growth factor β (TGFβ) levels in the conditioned media of human bone cells: Relationship to donor age, bone volume, and concentration of TGFβ in human bone matrix in vivo
24. Cytokines, bone remodeling, and estrogen deficiency: A 1998 update
25. Estrogen and raloxifene stimulate transforming growth factor-β3 gene expression in rat bone: A potential mechanism for estrogen- or raloxifene-mediated bone maintenance